Macquarie Group
AMED

Macquarie Group’s Amedisys AMED Stock Holding History

Macquarie Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-141
Closed -$13.1K – 1643
2025
Q1 		$13.1K Buy
+141
New +$13K ﹤0.01% 1626
2024
Q2 		– Sell
-196
Closed -$18 – 1906
2024
Q1 		$18 Buy
+196
New +$18.4K ﹤0.01% 1694
2022
Q4 		– Sell
-431
Closed -$73K – 1761
2022
Q3 		$73K Sell
431
-328
-43% -$39.1K ﹤0.01% 1846
2022
Q2 		$80K Hold
759
– – ﹤0.01% 1923
2022
Q1 		$131 Hold
759
– – ﹤0.01% 1886
2021
Q4 		$123K Sell
759
-126
-14% -$20.2K ﹤0.01% 1872
2021
Q3 		$132K Sell
885
-245
-22% -$50.9K ﹤0.01% 1891
2021
Q2 		$277K Sell
1,130
-235
-17% -$61.7K ﹤0.01% 1750
2021
Q1 		$361K Sell
1,365
-8,916
-87% -$2.51M ﹤0.01% 1581
2020
Q4 		$3.02M Sell
10,281
-646
-6% -$166K ﹤0.01% 987
2020
Q3 		$2.58M Sell
10,927
-193
-2% -$43.9K ﹤0.01% 973
2020
Q2 		$2.21M Sell
11,120
-9,921
-47% -$1.85M ﹤0.01% 984
2020
Q1 		$3.86M Sell
21,041
-3,345
-14% -$595K 0.01% 770
2019
Q4 		$4.07M Buy
24,386
+9,582
+65% +$1.43M 0.01% 858
2019
Q3 		$1.94M Sell
14,804
-4,449
-23% -$579K ﹤0.01% 1032
2019
Q2 		$2.34M Sell
19,253
-482
-2% -$57.2K ﹤0.01% 978
2019
Q1 		$2.43M Buy
19,735
+9,700
+97% +$1.22M ﹤0.01% 949
2018
Q4 		$1.18M Buy
10,035
+9,535
+1,907% +$1.12M ﹤0.01% 1106
2018
Q3 		$62K Buy
+500
New +$55.2K ﹤0.01% 1685
2018
Q1 		– Sell
-900
Closed -$47K – 2162
2017
Q4 		$47K Buy
+900
New +$47.4K ﹤0.01% 2000
2013
Q3 		– Sell
-60,000
Closed -$697K – 1606
2013
Q2 		$697K Buy
+60,000
New +$687K ﹤0.01% 1223

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Macquarie Group's AMED Position: Q2 2025 in Review

Macquarie Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 141 shares — an estimated $13.1K sold.

Macquarie Group first reported a position in AMED in Q2 2013 and held it in 21 quarters. The position peaked at $4.07M in Q4 2019. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Macquarie Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Macquarie Group sold 141 Amedisys shares in Q2 2025, an estimated $13.1K.
  • Macquarie Group first reported a position in Amedisys in Q2 2013 and held it in 21 quarters.
  • Macquarie Group's Amedisys position peaked at $4.07M in Q4 2019.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.